Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Final Provider-Administered Drug Precertification Policies .

Actemra; Tofidence; Tyenne; Avtozma; Tocilizumab-anoh; Tocilizumab-aazg

H.P. Acthar, Cortrophin

Aldurazyme

Aloxi, Posfrea

Benlysta IV

Berinert

Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu

Cerezyme

Cimzia

Elaprase

Fabrazyme

Herceptin, Ogivri, Kanjinti, Trazimera, Herzuma, Ontruzant, Hercessi, Trastuzumab-pkrb

Hizientra, Gammagard Liquid, Gamunex-C, Gammaked, Hyqvia, Cuvitru, Cutaquig, Xembify

Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Monovisc, Orthovisc, Supartz/Supartz FX, Synojoynt, Synvisc, Synvisc-One, TriVisc, VISCO-3, Triluron, sodium hyaluronate 1%

 

Alyglo, Bivigam, Flebogamma, Gamunex-C, Gammagard Liquid, Gammagard S/D, Gammaked, Gammaplex, Octagam, Privigen, Panzyga

Lenmeldy

Lucentis, Byooviz, Cimerli

Lumizyme

print Print Back Back Macugen® (pegaptanib) Policy Number: PH-0081   Intravitreal   Last Review Date:...

Naglazyme